Filing Details

Accession Number:
0001140361-10-046598
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-11-19 15:50:45
Reporting Period:
2010-11-17
Filing Date:
2010-11-19
Accepted Time:
2010-11-19 15:50:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1221599 Steve Aselage C/O Biomarin Pharmaceutical Inc.
105 Digital Drive
Novato CA 94949
Evp, Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-10-29 294 $11.64 37,881 No 5 A Direct
Common Stock Acquisiton 2010-11-17 8,000 $25.75 29,881 No 4 S Direct
Common Stock Acquisiton 2010-11-17 500 $14.39 30,381 No 4 M Direct
Common Stock Acquisiton 2010-11-18 31,375 $14.39 61,756 No 4 M Direct
Common Stock Disposition 2010-11-17 500 $25.80 61,256 No 4 S Direct
Common Stock Disposition 2010-11-18 31,375 $25.87 29,881 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 A Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2010-11-17 500 $0.00 500 $14.39
Common Stock Stock Option (right to buy) Disposition 2010-11-18 31,375 $0.00 31,375 $14.39
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
434,500 2009-11-12 2019-05-11 No 4 M Direct
403,125 2009-11-12 2019-05-11 No 4 M Direct
Footnotes
  1. The reporting person is voluntarily reporting the acquisition of shares of the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of May 2, 1010 to October 29, 2010.
  2. The price in Column 4 is a weighted average price. The prices actually received range from $25.80 to $26.02. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  3. Original option vests 6/48ths on November 12, 2009 and 1/48th on the 12th of every month thereafter.